You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫藥(03320.HK)旗下靜注人免疫球蛋白獲巴基斯坦註冊批件
阿思達克 02-02 09:09
華潤醫藥(03320.HK)宣布,旗下華潤博雅生物近日收到巴基斯坦政府國家衛生服務、法規和協調部及巴基斯坦藥品監督管理局批發的靜注人免疫球蛋白(pH4)註冊批件,編號為F.3-179/2018AD(BD)(V-I)(M-291)。 公司指出,是次兩種規格的靜注人免疫球蛋白(pH4)獲得巴基斯坦的藥品註冊,表明該產品已獲得巴基斯坦進口和銷售的批准,將有利於提高華潤醫藥產品海外市場註冊的積極性及動力,同時進一步提升公司產品的市場競爭力,對整體經營產生積極影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account